Advertisement

The Advanced Breast Cancer Nurse: A Key Role in the Metastatic Breast Cancer Patient Health Itinerary

  • Suzanna WinstonEmail author
Chapter
Part of the Principles of Specialty Nursing book series (PSN)

Abstract

Hundreds of thousands of women in the world are currently living with metastatic breast cancer. Thanks to the large advances in treatment, it is becoming a chronic disease. These patients express, through questionnaires, their poor quality of life, confusion when faced with the complexity of their healthcare, and a deep feeling of loneliness. The supportive care of these patients in Europe is still largely undeveloped. Within a multidisciplinary team, the advanced breast cancer nurse (ABCN) will play the key role in supportive care from discovery of metastasis, until the patient is transferred to palliative care. The presence of an ABCN should be formalized and funded in all breast cancer facilities. The creation of a healthcare track for metastatic breast cancer patients will facilitate the integration of the nurse into this role and help her to accomplish the mission.

Keywords

Advanced breast cancer Advanced breast cancer nurse Clinical role Supportive care Quality of life 

References

  1. 1.
    Aranda S, et al. Mapping the quality of life and unmet needs of urban women with metastatic breast cancer. Eur J Cancer Care. 2005;14:211–22.CrossRefGoogle Scholar
  2. 2.
    Aranda S, et al. Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial. Br J Cancer. 2006;95:667–73.CrossRefGoogle Scholar
  3. 3.
    Berman A, et al. Incidence and patterns of distant metastases for patients with early-stage breast cancer after conservation treatment. Clin Breast Cancer. 2013;13:88.CrossRefGoogle Scholar
  4. 4.
    Cardoso F, et al. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii11–9.CrossRefGoogle Scholar
  5. 5.
    Cardoso F, et al. 3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3). Ann Oncol. 2016;28:16–33.PubMedCentralGoogle Scholar
  6. 6.
    Chia S, et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer. 2007;110:973–9.CrossRefGoogle Scholar
  7. 7.
    daCosta DiBonaventura M, et al. Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer. Am Health Drug Benefits. 2014;7:386–96.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Eicher, et al. Training breast care nurses throughout Europe: the EONS post basic curriculum for breast cancer nursing. Eur J Cancer. 2012;48:1257–62.CrossRefGoogle Scholar
  9. 9.
    European Cancer Organization (ECCO). Value of specialized cancer nursing: position statement. 2017; http://www.oeci.eu/Attachments/ECCO_position_paper_Value_of_Specialised_Cancer_Nursing_FINAL.pdf. Accessed 18 Mar 2018.
  10. 10.
    Hagerty R, et al. Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol. 2005;23:1278–88.CrossRefGoogle Scholar
  11. 11.
    Johnston S, Swanton C, editors. Handbook of metastatic breast cancer. Abingdon: Informa Healthcare; 2006.Google Scholar
  12. 12.
    Kobayashi K, et al. Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer. Surg Today. 2016;46:821–6.CrossRefGoogle Scholar
  13. 13.
    Northouse L, et al. A family-based program of care for women with recurrent breast cancer and their family members. Oncol Nurs Forum. 2002;29:1411–9.CrossRefGoogle Scholar
  14. 14.
    Reed E, et al. A survey of provision of breast care nursing for patients with metastatic breast cancer – implications for the role. Eur J Cancer Care. 2010;19:575–80.CrossRefGoogle Scholar
  15. 15.
    Reed E, et al. Quality of life and experience of care in women with metastatic breast cancer: a cross-sectional survey. J Pain Symptom Manag. 2012;43:747–58.CrossRefGoogle Scholar
  16. 16.
    Sundquist M, et al. Trends in survival in metastatic breast. Cancer Eur J Cancer. 2010;8:191.CrossRefGoogle Scholar
  17. 17.
    Torre L, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefGoogle Scholar
  18. 18.
    Vila C, et al. Advanced breast cancer clinical nursing curriculum: review and recommendations. Clin Transl Oncol. 2017;19:251–60.CrossRefGoogle Scholar
  19. 19.
    Warren M, et al. Co-ordination of supportive care needs in metastatic breast cancer. Cancer Nurs Pract. 2014;13:23–7.CrossRefGoogle Scholar
  20. 20.
    Walker MS, Masaquel AS, Kerr J, et al. Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden. Breast Cancer Res Treat. 2014;144(3):673–81.CrossRefGoogle Scholar
  21. 21.
    World Health Organization. Projections of mortality and causes of death, 2015 and 2030. http://www.who.int/healthinfo/globalburdendisease/projections/en/. Updated July 2013. Accessed 27 Sept 2015.
  22. 22.
    Yate P, et al. Competency standards and educational requirements for specialist breast nurses in Australia. Collegian. 2007;14:11–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Cliniques Universitaires Saint-LucUniversité Catholique de LouvainBrusselsBelgium

Personalised recommendations